G.D./B-ORG Searle/I-ORG -AMP-/I-ORG Co./I-ORG said/O the/B-ORG Food/I-ORG and/I-ORG Drug/I-ORG Administration/I-ORG approved/O the/O sale/O of/O Kerlone/O ,/O a/O hypertension/O drug/O developed/O by/O a/O joint/O venture/O between/O Searle/B-ORG and/O a/O French/O concern/O ./O
Searle/B-ORG ,/O a/O unit/O of/O Monsanto/B-ORG Co./I-ORG ,/O said/O the/O ``/O beta/O -/O blocker/O ''/O high/O -/O blood/O -/O pressure/O drug/O Kerlone/O is/O the/O first/O product/O to/O reach/O the/O market/O through/O Lorex/B-ORG Pharmaceuticals/I-ORG ,/O the/O U.S./B-GPE company/O jointly/O owned/O by/O Searle/B-ORG and/O Synthelabo/B-ORG ,/O a/O French/O pharmaceutical/O concern/O owned/O by/O France/B-GPE 's/O L'Oreal/B-ORG S.A/I-ORG ./O
